Efficacy and safety of ciprofol versus remimazolam combined with alfentanil for sedation during outpatient colonoscopy: a randomized double-blind noninferiority trial
Brazilian Journal of Anesthesiology (English Edition) · 2026
DOI: 10.1016/j.bjane.2026.844824 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Brazilian Journal of Anesthesiology (English Edition), 2026. Verfasst von Xuan Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Dalian Medical University, Department of Anesthesiology, Dalian, China. Hauptthemen laut MEDLINE: Alfentanil, Colonoscopy, Hypnotics and Sedatives, Procedural Sedation. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
INTRODUCTION: Colonoscopy often causes significant discomfort to patients. To improve patient experience, sedation-assisted colonoscopy is being increasingly adopted. This study was designed to assess the efficacy and safety of ciprofol versus remimazolam combined with alfentanil during outpatient colonoscopy. METHODS: A randomized, double-blind controlled clinical trial was performed among patients scheduled for elective outpatient colonoscopy. Patients were randomly allocated at a 1:1 ratio to two groups: the ciprofol group (Group C, 0.4 mg.kg-1 intravenously, n = 88) and the remimazolam group (Group R, 0.3 mg.kg-1 intravenously, n = 88). Intravenous alfentanil (3 μg.kg-1) was administered to all patients in conjunction with the study drug. The primary outcome was the success rate of colonoscopy. Secondary outcomes included induction time, discharge time, satisfaction levels (patients and endoscopists), and adverse events. RESULTS: In the ITT population, colonoscopy success rates were 100.0% (88/88) in Group C and 98.9% (87/88) in Group R (treatment difference [95% CI]: 0.011 [-0.024 to 0.048]). The lower bound of the two-sided 95% CI was above the prespecified noninferiority margin of -0.08, confirming the noninferiority of ciprofol relative to remimazolam. After Bonferroni correction (adjusted threshold p < 0.0028), discharge time was longer in Group C (8.5 [6.0‒12.0] vs. 7.0 [5.0‒9.0] minutes; p = 0.002). Group R showed numerically higher MAP and HR at several time points. CONCLUSIONS: This study demonstrated that intravenous ciprofol (0.4 mg.kg-1) or remimazolam (0.3 mg.kg-1), combined with alfentanil (3 μg.kg-1), provided effective sedation for outpatient colonoscopy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Dalian Medical University, Department of Anesthesiology, Dalian, China.
- People's Hospital of Liaoning Province (Peoples' Hospital of China Medical University), Department of Anesthesiology, Shenyang, China.
- People's Hospital of Liaoning Province (Peoples' Hospital of China Medical University), Department of Anesthesiology, Shenyang, China. Electronic address: teamwangcm@163.com.
- People's Hospital of Liaoning Province (Peoples' Hospital of China Medical University), Department of Neurosurgery, Shenyang, China.
Zitieren
APA
Liu, X., Tang, Q., Zou, N., Wang, C., & Guo, X. (2026). Efficacy and safety of ciprofol versus remimazolam combined with alfentanil for sedation during outpatient colonoscopy: a randomized double-blind noninferiority trial. Brazilian Journal of Anesthesiology (English Edition). https://doi.org/10.1016/j.bjane.2026.844824
Vancouver
Liu X, Tang Q, Zou N, Wang C, Guo X. Efficacy and safety of ciprofol versus remimazolam combined with alfentanil for sedation during outpatient colonoscopy: a randomized double-blind noninferiority trial. Brazilian Journal of Anesthesiology (English Edition). 2026. doi:10.1016/j.bjane.2026.844824
BibTeX
@article{Liu2026,
author = {Liu, Xuan and Tang, Qianqian and Zou, Ning and Wang, Changming and Guo, Xuejun},
title = {Efficacy and safety of ciprofol versus remimazolam combined with alfentanil for sedation during outpatient colonoscopy: a randomized double-blind noninferiority trial},
journal = {Brazilian Journal of Anesthesiology (English Edition)},
year = {2026},
doi = {10.1016/j.bjane.2026.844824}
}
EUVIMED